The Fanconi Anemia Center is one of the few places in the United States capable where families dealing with Fanconi anemia (FA) can receive comprehensive care plus access to the newest specialized treatments. We have experience and the range of services to handle the complex needs of any FA patient.
This depth and quality of FA resources derives directly from our three founding organizations:
- Seattle Children’s Hospital provides top-rated care in all the specialties needed by FA patients (ranked 7th nationally by U.S. News & World Report).
- Fred Hutchinson Cancer Research Center has created many of the techniques now used worldwide to transplant patients with FA and other bone marrow failure disorders.
- University of Washington Medical Center is a hub of innovative research on new genomic therapies for rare diseases such as FA.
Many FA patients will benefit from care at an FA center that offers high quality, multidisciplinary specialty services and standard transplantation as well as a direct line to emerging treatments—therapies such as alternative donor transplants (we are among the most successful in the nation) and new gene therapy techniques (our FA Center recently began the world’s first lentivirus vector-based gene therapy trial for FA patients).
Our pediatric bone marrow experts and transplant specialists are ready to assist FA patients of any age, newly diagnosed, or previously treated, and with any special complications or conditions. Our specialists have now done more than 14,000 transplants—more than any institution in the world. This includes nearly 400 transplants in children with rare nonmalignant conditions such as aplastic anemia. In fact, we have done more unrelated donor transplants for patients with severe aplastic anemia than any other transplant center in the U.S. and we consistently rank among the top transplant centers in 1-year survival rates after unrelated donor transplants.
Families dealing with marrow disorders come to us from around the world. They come for our outstanding FA pediatric specialists, our transplant program, and our world-class research. They receive a lifetime of care and hope.